https://www.avient.com/sites/default/files/2023-03/2023 Avient Bookmarked Proxy Statement - FINAL.pdf
Online access will begin at 8:45 a.m.
Tax Fees.
Tax services include tax compliance, tax advice and tax planning.
https://www.avient.com/investors/investor-contacts
Reporting & SEC Filings
https://www.avient.com/sites/default/files/2025-05/Avient Announces First Quarter 2025 Results_0.pdf
To access Avient’s news library online, please visit www.avient.com/news.
Three Months Ended March 31,
2025 2024
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1)
Net (loss) income attributable to Avient common shareholders $ (20.2) $ (0.22) $ 49.4 $ 0.54
Special items, after-tax (Attachment 3) 75.7 0.82 5.5 0.06
Amortization expense, after-tax 14.5 0.16 14.9 0.16
Adjusted net income / EPS $ 70.0 $ 0.76 $ 69.8 $ 0.76
(1) Per share amounts may not recalculate from figures presented herein due to rounding
7
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
March 31,
2025 2024
Sales $ 826.6 $ 829.0
Cost of sales 563.4 550.8
Gross margin 263.2 278.2
Selling and administrative expense 262.5 184.2
Operating income 0.7 94.0
Interest expense, net (26.9) (26.6)
Other expense, net (0.4) (0.9)
(Loss) income before income taxes (26.6) 66.5
Income tax benefit (expense) 6.7 (16.8)
Net (loss) income $ (19.9) $ 49.7
Net income attributable to noncontrolling interests (0.3) (0.3)
Net (loss) income attributable to Avient common shareholders $ (20.2) $ 49.4
(Loss) earnings per share attributable to Avient common shareholders - Basic: $ (0.22) $ 0.54
(Loss) earnings per share attributable to Avient common shareholders - Diluted: $ (0.22) $ 0.54
Cash dividends declared per share of common stock $ 0.2700 $ 0.2575
Weighted-average shares used to compute (loss) earnings per common share:
Basic 91.5 91.2
Diluted 91.5 92.0
8
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1)
Three Months Ended
March 31,
2025 2024
Cost of sales:
Restructuring costs, including accelerated depreciation $ (4.1) $ 3.6
Environmental remediation costs (4.9) (4.0)
Reimbursement of previously incurred environmental costs 1.3 —
Impact on cost of sales (7.7) (0.4)
Selling and administrative expense:
Restructuring and employee separation costs (5.1) (0.7)
Legal and other (0.4) (3.5)
Cloud-based enterprise resource planning system impairment (86.3) —
Acquisition related costs — (1.6)
Impact on selling and administrative expense (91.8) (5.8)
Impact on operating income (99.5) (6.2)
Interest expense, net - financing costs (1.7) —
Impact on (loss) income before income taxes (101.2) (6.2)
Income tax benefit on special items 25.5 1.4
Tax adjustments(2) — (0.7)
Impact of special items on net (loss) income $ (75.7) $ (5.5)
Diluted (loss) earnings per common share impact $ (0.82) $ (0.06)
Weighted average shares used to compute adjusted earnings per share:
Diluted 91.8 92.0
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs,
fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on facility or
property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose
prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or
other such laws or provisions affecting reported results
Three Months Ended
March 31,
Reconciliation to Consolidated Statements of Income 2025 2024
Sales $ 826.6 $ 829.0
Gross margin - GAAP 263.2 278.2
Special items in gross margin (Attachment 3) 7.7 0.4
Adjusted gross margin $ 270.9 $ 278.6
Adjusted gross margin as a percent of sales 32.8 % 33.6 %
Operating income - GAAP 0.7 94.0
Special items in operating income (Attachment 3) 99.5 6.2
Adjusted operating income $ 100.2 $ 100.2
Adjusted operating income as a percent of sales 12.1 % 12.1 %
Three Months Ended
March 31,
Reconciliation to EBITDA and Adjusted EBITDA: 2025 2024
Net (loss) income – GAAP $ (19.9) $ 49.7
Income tax (benefit) expense (6.7) 16.8
Interest expense, net 26.9 26.6
Depreciation & amortization 45.3 44.3
EBITDA $ 45.6 $ 137.4
Special items, before tax 101.2 6.2
Interest expense included in special items (1.7) —
Depreciation & amortization included in special items (0.4) (0.5)
Adjusted EBITDA $ 144.7 $ 143.1
Adjusted EBITDA as a percent of sales 17.5 % 17.3 %
13
Year Ended
December 31, 2024
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1)
Net income attributable to Avient common shareholders $ 169.5 $ 1.84
Special items, after-tax 15.9 0.17
Amortization expense, after-tax 59.5 0.65
Adjusted net income / EPS $ 244.9 $ 2.66
(1) Per share amounts may not recalculate from figures presented herein due to rounding
Three Months Ended
June 30, 2024
Reconciliation to Condensed Consolidated Statements of Income $ EPS(1)
Net income attributable to Avient common shareholders $ 33.6 $ 0.36
Special items, after-tax 21.8 0.24
Amortization expense, after-tax 14.8 0.16
Adjusted net income / EPS $ 70.2 $ 0.76
(1) Per share amounts may not recalculate from figures presented herein due to rounding
https://www.avient.com/news/avient-launches-new-bio-based-polymer-solutions-medical-and-pharmaceutical-applications-during-pharmapack-europe-2022
Documented change control beyond CAS number is practiced and Registered Drug Master File (DMF) / Device Master File (MAF) documentation is maintained.
To access Avient’s news library online, please visit www.avient.com/news.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:
Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully
integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and
cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate
liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and
timing of any future dividends;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital
reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;
An inability to maintain appropriate relations with unions and employees; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation.
• The above list of factors is not exhaustive.
• We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise.
The non‐GAAP financial measures
i l d dj t d EPS i b f i t t t d i ti dinclude: adjusted EPS, earnings before interest, tax, depreciation and
amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating
income, Specialty platform gross margin percentage, adjusted operating income,
return on invested capital, net debt/ EBITDA, and the exclusion of corporate p p
charges in certain calculations.
Platform operating income mix percentage 2005Y 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y
Global Specialty Engineered Materials $ 0.4 $ 3.9 $ 4.9 $ 17.6 $ 20.6 $ 49.7 $ 45.9
Global Color, Additives and Inks 4.3 8.9 25.7 28.1 25.2 37.7 43.4
Specialty Platform $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 89.3
Performance Products and Solutions 75.7 64.2 65.8 31.3 33.1 54.0 62.4
Distribution 19.5 19.2 22.1 28.1 24.8 42.0 56.0
SunBelt Joint Venture 91.9 102.9 34.8 28.6 25.5 18.9 5.0
Corporate (51.5) 34.5 (73.3) (425.1) 7.9 (27.7) 20.3
Operating income (loss) GAAP $ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 233.0
Less: Corporate operating expense (income) 51.5 (34.5) 73.3 425.1 (7.9) 27.7 (20.3)
Operating income excluding Corporate $ 191.8 $ 199.1 $ 153.3 $ 133.7 $ 129.2 $ 202.3 $ 212.7
Specialty platform operating mix percentage 2% 6% 20% 34% 35% 43% 42%
Platform operating income mix percentage 2012Y
Global Specialty Engineered Materials $ 47.0
Global Color, Additives and Inks 66.8
Specialty Platform $ 113.8
Performance Products and Solutions 74.9
Distribution 66.0
Corporate (87.6)
Operating income GAAP $ 167.1
Less: Corporate operating expense 87.6
Operating income excluding Corporate $ 254.7
Specialty platform operating mix percentage 45%
Platform sales and operating income (OI) 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y
Global Specialty Engineered Materials Sales $ 345.3 $ 384.4 $ 514.0 $ 402.9 $ 517.4 $ 575.1
Global Color, Additives and Inks Sales 531.8 560.5 554.3 459.8 527.4 544.6
Specialty Platform Sales $ 877.1 $ 944.9 $ 1,068.3 $ 862.7 $ 1,044.8 $ 1,119.7
Performance Products and Solutions Sales 1,166.2 1,086.8 1,001.4 667.7 776.3 865.4
PolyOne Distribution Sales 732.8 744.3 796.7 625.1 911.9 996.5
Corporate and Eliminations (153.7) (133.3) (127.7) (94.8) (111.1) (118.1)
Total Sales $ 2,622.4 $ 2,642.7 $ 2,738.7 $ 2,060.7 $ 2,621.9 $ 2,863.5
Global Specialty Engineered Materials OI $ 3.9 $ 4.9 $ 17.6 $ 20.6 $ 49.7 $ 45.9
Global Color, Additives and Inks OI 8.9 25.7 28.1 25.2 37.7 43.4
Specialty Platform OI $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 89.3
Performance Products and Solutions OI 64.2 65.8 31.3 33.1 54.0 62.4
PolyOne Distribution OI 19.2 22.1 28.1 24.8 42.0 56.0
Sunbelt Joint Venture OI 102.9 34.8 28.6 25.5 18.9 5.0
Corporate and eliminations (4.6) (25.5) (28.9) (40.8) (32.5) (26.4)
Special items in OI 39.1 (47.8) (396.2) 48.7 4.8 46.7
Operating income (loss) GAAP $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 233.0
Sunbelt equity income (107.0) (40.8) (32.5) (29.7) (23.1) (5.7)
Special items in OI (39.1) 47.8 396.2 (48.7) (4.8) (46.7)
Operating income adjusted $ 87.5 $ 87.0 $ 72.3 $ 58.7 $ 146.7 $ 180.6
Global Specialty Engineered Materials - OI
% of sales 1.1% 1.3% 3.4% 5.1%
9.6%
8.0%
Global Color, Additives and Inks - OI % of
sales 1.7% 4.6% 5.1% 5.5%
7.1%
8.0%
Specialty platform OI - % of sales 1.5% 3.2% 4.3% 5.3% 8.4% 8.0%
PP&S operating OI - % of sales 5.5% 6.1% 3.1% 5.0% 7.0% 7.2%
Distribution OI - % of sales 2.6% 3.0% 3.5% 4.0% 4.6% 5.6%
PolyOne OI adjusted - % of sales 3.3% 3.3% 2.6% 2.8% 5.6% 6.3%
Platform sales and operating income (OI) 2012Y 2012PF
Global Specialty Engineered Materials Sales $ 543.6 $ 779.5
Global Color, Additives and Inks Sales 703.5 753.8
Designed Structures & Solutions 847.4
Specialty Platform Sales $ 1,247.1 $ 2,380.7
Performance Products and Solutions Sales 837.0 902.8
PolyOne Distribution Sales 1,030.3 1,030.3
Corporate and Eliminations (121.8) (121.8)
Total Sales $ 2,992.6 $ 4,192.0
Global Specialty Engineered Materials OI $ 47.0
Global Color, Additives and Inks OI 66.8
Specialty Platform OI $ 113.8
Performance Products and Solutions OI 74.9
PolyOne Distribution OI 66.0
Corporate and eliminations (33.7)
Special items in OI (53.9)
Operating income - GAAP $ 167.1
Special items in OI 53.9
Operating income adjusted $ 221.0
Global Specialty Engineered Materials - OI % of sales 8.6%
Global Color, Additives and Inks - OI % of sales 9.5%
Specialty platform OI % of sales 9.1%
PP&S operating OI % of sales 9.0%
Distribution OI % of sales 6.4%
PolyOne OI adjusted, % of sales 7.4%
Adjusted EPS 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y 2012Y
Net Income attributable to PolyOne common
shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 162.6 $ 172.6 $ 71.9
SunBelt equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) -
Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7
Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 75.4 $ 96.1 $ 108.1
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.79 $ 1.02 $ 1.20
Average Debt Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Average
PolyOne Debt $ 707.0 $ 706.4 $ 705.8 $ 705.2 $ 706.9 $ 706.3
Average Equity Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Average
PolyOne shareholders’ equity $ 588.3 $ 611.3 $ 604.3 $ 629.3 $ 629.1 $ 612.5
Adjusted EBITDA 2012
PolyOne Income before income taxes $ 113.0
PolyOne Interest expense, net 50.8
PolyOne Depreciation and amortization 69.8
PolyOne Special items in EBITDA 55.1
PolyOne Adjusted EBITDA $ 288.7
Pro forma Spartech EBITDA * 56.3
Pro forma EBITDA * $ 345.0
* Amount excludes expected synergies.
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and
operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being
accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and
cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate
liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital
reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation
The non-GAAP financial measures
include: adjusted EPS, earnings before interest, tax, depreciation and
amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating
income, Specialty platform gross margin percentage, adjusted operating income,
return on invested capital, net debt/ EBITDA, and the exclusion of corporate
charges in certain calculations.
Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y
Net income attributable to PolyOne
common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0
SunBelt equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - -
Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4
Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.1
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/news/‘future-proof’-pharma-packaging-avient-launches-new-regulatory-compliant-mevopur-amber-masterbatches
To support customers’ Device Master File submission for healthcare materials, Avient has developed and submitted a type III Drug Master File (FDA) for these colorants.
To access Avient’s news library online, please visit www.avient.com/news.
https://www.avient.com/idea/material-solutions-expanding-ev-charging-infrastructure
Government funding and support through various laws, tax credits, and development grants indicates that public EV charging equipment production will likely continue on a high growth trajectory.
https://www.avient.com/investors/stock-information
Reporting & SEC Filings
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-1
news library online, please visit www.avient.com/news
SEC Filings